Skip to main content
Menu Icon
Close

InfoBytes Blog

Financial Services Law Insights and Observations

FTC files first action targeting paid reviews

Federal Issues FTC Act Advertisement Deceptive

Federal Issues

On February 26, the FTC announced its first action against a company for using fake paid reviews on an independent retail website in violation of the FTC Act. According to the complaint, the company—which advertised and sold a pill on a retail website as an appetite suppressant, fat blocker, and weight loss supplement—paid a website to create and post reviews of its supplement on the retail website in order to keep the supplement’s rating high. The FTC argues that paying for the fake reviews constitutes a deceptive act or practice and the making of false advertisements in violation of the FTC Act because the company represented the reviews as truthful comments by actual product purchasers. Moreover, the FTC alleges that the company made deceptive or false claims about the effectiveness of its supplement on the retail website because the claims were unsubstantiated at the time the representations were made. The proposed order imposes injunctive relief prohibiting the company from making similar claims related to similar dietary supplements unless there is reliable evidence from human clinical testing to support the claims, and from misrepresenting that an endorsement is truthful or from an actual purchaser. As part of the settlement, the company has agreed to a 12.8 million suspended judgment after the payment of $50,000 based on the company’s financial condition. The proposed order has not yet been approved by the district court.